Cargando…
Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
To perform an epidemiological evaluation of the predictive value of p53 autoantibodies in breast cancer, we measured antibodies against p53 in serum samples from 165 breast cancer patients in comparison with serum samples from 330 healthy controls, selected from the same population as the cases and...
Autores principales: | Lenner, P, Wiklund, F, Emdin, S O, Arnerlöv, C, Eklund, C, Hallmans, G, Zentgraf, H, Dillner, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362685/ https://www.ncbi.nlm.nih.gov/pubmed/10070892 http://dx.doi.org/10.1038/sj.bjc.6690148 |
Ejemplares similares
-
Serum p53 antibodies: predictors of survival in small-cell lung cancer?
por: Murray, P V, et al.
Publicado: (2000) -
Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status.
por: Nielsen, N. H., et al.
Publicado: (1996) -
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999) -
Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999) -
Antibodies against p53 are associated with poor prognosis of colorectal cancer.
por: Houbiers, J. G., et al.
Publicado: (1995)